Get the Stockscreener App
22.04
2.27%
0.49
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $22.04, with a volume of 10.26M.
It is up +2.27% in the last 24 hours and up +13.73% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$21.55
Open:
$21.47
24h Volume:
10.26M
Relative Volume:
1.40
Market Cap:
$11.38B
Revenue:
$11.32B
Net Income/Loss:
$-981.00M
P/E Ratio:
-11.28
EPS:
-1.9532
Net Cash Flow:
$714.00M
1W Performance:
+10.81%
1M Performance:
+13.73%
6M Performance:
+13.73%
1Y Performance:
-27.74%
1-Day Range:
$21.43
$22.18
1-Week Range:
$19.42
$22.18
52-Week Range:
$15.73
$31.75
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
22.04 | 11.38B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
404.70 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.92 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.80 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.87 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
200.29 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Downgrade | Argus | Buy → Hold |
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Baxter International edges higher with sector peers, shares trade on NYSE - Ad-hoc-news.de
Baxter's unit Synovis MCA to lead global rollout of the SHIYA platform - MSN
The PrisMax System from Baxter International Inc.flexible CRRT for fragile ICU patients - Ad-hoc-news.de
Is Baxter International stock underperforming the S&P 500? - MSN
Baxter International focuses on long-term portfolio shift, shares in S&P 500 healthcare spotlight - Ad-hoc-news.de
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Enterprise value to EBIT forward of Baxter International Inc. – NYSE:BAX - TradingView
Baxter International weekly move, shares lag key healthcare peers - Ad-hoc-news.de
Price to sales forward of Baxter International Inc. – NYSE:BAX - TradingView
Price to earnings forward of Baxter International Inc. – NYSE:BAX - TradingView
Enterprise value to revenue forward of Baxter International Inc. – NYSE:BAX - TradingView
Baxter International Inc. Actuals & Estimates (NYSE:BAX) - TradingView
Baxter International consensus picture builds, shares trade below recent highs - Ad-hoc-news.de
Enterprise value to EBIT forward of Baxter International Inc. – HAM:BTL - TradingView
Biotin Vitamin Supplement Market Growth Outlook to 2035: Fermentation Demand and Supply DynamicsNews and Statistics - IndexBox
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges - GuruFocus
'Family Ties' star Michael Gross celebrates TV wife Meredith Baxter as they turn 79 - Toronto Sun
CardioMech Shareholders Appoint Ramin Mousavi as Chairman of the Board | Newswise - Newswise
Albireo Energy in Edison appoints Baxter as CEO - ROI-NJ
Baxter International focuses on dialysis and hospital portfolio, shares on NYSE under analyst watch - Ad-hoc-news.de
US FDA Turns to Indian Drugmakers as Critical Cancer Medicine Shortage Deepens - slguardian.org
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact - StreetInsider
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare Challenges with a Potential 8.3% Upside - DirectorsTalk Interviews
Baxter International StockWeekly outlook with earnings ahead - Ad-hoc-news.de
Postmedia's Vaughn Palmer, Bruce MacKinnon share 2026 Michener-Baxter Award honours - National Post
Famous birthdays for June 21: Prince William, Meredith Baxter - upi.com
Baxter International (BAX) Stock Could Be 7.7% Undervalued After MediThinQ Distribution Deal - Sahm
Quietly crucial on the ward, Baxter’s Sigma Spectrum infusion pump in everyday use - AD HOC NEWS
Why Baxter’s Spectrum IQ smart pump is drawing fresh attention in hospitals - AD HOC NEWS
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform - Yahoo Finance
Business News - LatestLY
Quietly precise, Baxter Spectrum IQ aims to make IV pumps less stressful - AD HOC NEWS
Baxter International Inc (BAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Baxter International Inc (BAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Smart safety touches, Baxter Spectrum IQ pump aims for quieter hospital days - AD HOC NEWS
symbol__ Stock Quote Price and Forecast - CNN
MediThinQ partners with Baxter unit to distribute 3D platform - Investing.com
Baxter International Unit Signs Distribution Deal for Surgical Visualization Platform - Moomoo
MediThinQ partners with Baxter unit to distribute 3D platform By Investing.com - Investing.com India
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MSN
Investors who lost money with shares of ADMA Biologics, Inc. - openPR.com
Baxter International Inc (BAX) Stock Down 5.2% -- Now Undervalued? GF Score: 60/100 - GuruFocus
Baxter International Inc (BAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Baxter International Inc (BAX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Baxter International Inc (BAX) Institutional Confidence - TradingKey
Baxter International Inc (BAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Baxter International Inc (BAX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Baxter International Inc (BAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is Baxter International Stock Underperforming the S&P 500? - Barchart.com
Baxter’s Post-Divestiture Profit Focus Might Change The Case For Investing In Baxter International (BAX) - simplywall.st
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):